Colbert L, Jia Y, Sharma A, Hu J, et al. FDA Approval Summary: Nadofaragene firadenovec-vncg for bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer. Clin Cancer Res 2024 Dec 20. doi: 10.1158/1078-0432.CCR-24-2812.
PMID: 39705065